Electroconvulsive therapy and informed consent: navigating clinical efficacy and patient rights

Electroconvulsive therapy and informed consent: navigating clinical efficacy and patient rights
Conference Presentation
Anghel Claudia
Beyond borders: united for mental health 2024; Chişinău, Moldova, 10-13 October 2024
Abstract
Electroconvulsive Therapy (ECT) remains a highly effective treatment for severe mental health disorders, such as treatment-resistant schizophrenia and major depressive disorder. However, its use raises important ethical and legal concerns, particularly regarding informed consent. Balancing the clinical efficacy of ECT with patients’ rights to make informed decisions about their treatment is a complex challenge for mental health professionals. Informed consent is crucial, requiring that patients fully understand the potential benefits, risks, and side effects of ECT before agreeing to the procedure. Mental health care providers must ensure that patients are not only informed about the short- and long-term effects of ECT but also supported in their decisionmaking process. This includes addressing any cognitive impairments or mental health symptoms that may impact their capacity to give informed consent. Additionally, legal guardians or family members may be involved in the consent process, especially when patients are unable to provide it themselves. Ultimately, navigating the delicate balance between ensuring the clinical success of ECT and respecting patient autonomy is essential for ethical practice. Continued research into improving patient education and consent processes can help to understand the efficacy of ECT and the rights of them receiving this treatment.